Schall Law Firm Announces Investigation into ORIC Pharmaceuticals on Behalf of Investors
The Schall Law Firm announced an investigation on April 22, 2026, into claims that ORIC Pharmaceuticals, Inc. violated securities laws through false or misleading statements. The probe targets disclosures related to investors. ORIC, which trades on NASDAQ under ORIC, recently announced rinzimetostat (ORIC-944).
Substrate placeholder — needs reviewLOS ANGELES, April 22, 2026 (Substrate) -- The Schall Law Firm announced an investigation into claims on behalf of investors of ORIC Pharmaceuticals, Inc. for violations of securities laws. The announcement came on Tuesday from the national shareholder rights litigation firm based in Los Angeles.
The investigation focuses on whether ORIC Pharmaceuticals, Inc. issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Benzinga reported that the probe examines potential lapses in transparency affecting shareholder interests.
ORIC Pharmaceuticals, Inc. trades on NASDAQ under the ticker symbol ORIC. ORIC Pharmaceuticals, Inc. announced rinzimetostat (ORIC-944), a development that has drawn scrutiny in the context of the investigation.
The firm stated it is pursuing claims to protect investors who may have suffered losses due to alleged securities violations. No specific timeline for the investigation's outcome has been disclosed.
Key Facts
Story Timeline
2 events- 2026-04-22
The Schall Law Firm announced investigation into ORIC Pharmaceuticals for securities violations.
1 sourceThe Schall Law Firm - Recent (undated in source)
ORIC Pharmaceuticals announced rinzimetostat (ORIC-944).
1 sourceORIC Pharmaceuticals, Inc.
Potential Impact
- 01
Increased scrutiny on ORIC's disclosures, possibly affecting stock volatility.
- 02
Potential recovery for affected investors through litigation.
- 03
Broader implications for pharmaceutical firms' transparency practices.
Transparency
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
jpost.comEbola Cases in Central Africa Rise from 256 to About 1,000 in Eleven Days
Suspected and confirmed Ebola cases in the Democratic Republic of the Congo and Uganda increased from 256 on 16 May to roughly 1,000 by 27 May. The World Health Organization reported about 240 deaths during the same period.
thestreet.comU.S. Space Force Awards SpaceX $4.16 Billion Satellite Contract
The U.S. Space Force awarded SpaceX a $4.16 billion contract to build a satellite network for tracking airborne targets. The award is part of $6.4 billion in new contracts given to the company in the past week.